_id
690dafdeccc777a4e85d0b36
Ticker
APNHF
Name
Aspen Pharmacare Holdings Limited
Exchange
PINK
Address
Aspen Place, Durban, South Africa
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.aspenpharma.com
Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Last Close
6.23
Volume
100
Current Price
6.23
Change
0
Last Updated
2025-11-28T12:18:30.915Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
2766260480
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
21403000000
Cost Of Revenue
12728000000
Gross Profit
8675000000
Operating Expenses
5622000000
Operating Income
3053000000
Interest Expense
888000000
Pretax Income
-3308000000
Net Income
-3471000000
Eps
-7.81580725061923
Dividends Per Share
-
Shares Outstanding
444022553
Income Tax Expense
163000000
EBITDA
-2258000000
Operating Margin
14.264355464187265
Total Other Income Expense Net
-6361000000
Cash
6409000000
Short Term Investments
-
Receivables
13339000000
Inventories
18009000000
Total Current Assets
38702000000
Property Plant Equipment
21707000000
Total Assets
135893000000
Payables
10675000000
Short Term Debt
4612000000
Long Term Debt
31508000000
Total Liabilities
51000000000
Equity
84893000000
Depreciation
1050000000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
PE
-
PB
0.03259094389407843
ROE
-4.088676333737764
ROA
-2.5542154489193702
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
37
Deep Value Investing Score
6
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
5.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
21403000000
Quarters > 0 > income Statement > cost Of Revenue
12728000000
Quarters > 0 > income Statement > gross Profit
8675000000
Quarters > 0 > income Statement > operating Expenses
5622000000
Quarters > 0 > income Statement > operating Income
3053000000
Quarters > 0 > income Statement > interest Expense
888000000
Quarters > 0 > income Statement > pretax Income
-3308000000
Quarters > 0 > income Statement > net Income
-3471000000
Quarters > 0 > income Statement > eps
-7.81580725061923
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
444100000
Quarters > 0 > income Statement > income Tax Expense
163000000
Quarters > 0 > income Statement > EBITDA
-2258000000
Quarters > 0 > income Statement > operating Margin
14.264355464187265
Quarters > 0 > income Statement > total Other Income Expense Net
-6361000000
Quarters > 0 > balance Sheet > cash
6409000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
13339000000
Quarters > 0 > balance Sheet > inventories
18009000000
Quarters > 0 > balance Sheet > total Current Assets
38702000000
Quarters > 0 > balance Sheet > property Plant Equipment
21707000000
Quarters > 0 > balance Sheet > total Assets
135893000000
Quarters > 0 > balance Sheet > payables
10675000000
Quarters > 0 > balance Sheet > short Term Debt
4612000000
Quarters > 0 > balance Sheet > long Term Debt
31508000000
Quarters > 0 > balance Sheet > total Liabilities
51000000000
Quarters > 0 > balance Sheet > equity
84893000000
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
1050000000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
-7.81580725061923
Quarters > 0 > ratios > PB
0.03259094389407843
Quarters > 0 > ratios > ROE
-4.088676333737764
Quarters > 0 > ratios > ROA
-2.5542154489193702
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
21960000000
Quarters > 1 > income Statement > cost Of Revenue
11506000000
Quarters > 1 > income Statement > gross Profit
10454000000
Quarters > 1 > income Statement > operating Expenses
10443000000
Quarters > 1 > income Statement > operating Income
11000000
Quarters > 1 > income Statement > interest Expense
652000000
Quarters > 1 > income Statement > pretax Income
3185000000
Quarters > 1 > income Statement > net Income
2388000000
Quarters > 1 > income Statement > eps
5.377167304661112
Quarters > 1 > income Statement > dividends Per Share
1601000000
Quarters > 1 > income Statement > shares Outstanding
444100000
Quarters > 1 > income Statement > income Tax Expense
797000000
Quarters > 1 > income Statement > EBITDA
4935000000
Quarters > 1 > income Statement > operating Margin
0.05009107468123861
Quarters > 1 > income Statement > total Other Income Expense Net
3174000000
Quarters > 1 > balance Sheet > cash
6804000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
13341000000
Quarters > 1 > balance Sheet > inventories
18868000000
Quarters > 1 > balance Sheet > total Current Assets
40454000000
Quarters > 1 > balance Sheet > property Plant Equipment
21151000000
Quarters > 1 > balance Sheet > total Assets
136600000000
Quarters > 1 > balance Sheet > payables
9845000000
Quarters > 1 > balance Sheet > short Term Debt
4574000000
Quarters > 1 > balance Sheet > long Term Debt
30897000000
Quarters > 1 > balance Sheet > total Liabilities
51514000000
Quarters > 1 > balance Sheet > equity
85086000000
Quarters > 1 > cash Flow > net Income
2388000000
Quarters > 1 > cash Flow > depreciation
1039000000
Quarters > 1 > cash Flow > change In Working Capital
-2336000000
Quarters > 1 > cash Flow > cash From Operations
1805000000
Quarters > 1 > cash Flow > capital Expenditures
1197000000
Quarters > 1 > cash Flow > cash From Investing
-2791000000
Quarters > 1 > cash Flow > cash From Financing
959000000
Quarters > 1 > cash Flow > net Change In Cash
6804000000
Quarters > 1 > ratios > PE
5.377167304661112
Quarters > 1 > ratios > PB
0.032517018075829164
Quarters > 1 > ratios > ROE
2.8065721740356815
Quarters > 1 > ratios > ROA
1.7481698389458271
Quarters > 1 > ratios > FCF
608000000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.027686703096539162
Quarters > 1 > health Score
50
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
23565000000
Quarters > 2 > income Statement > cost Of Revenue
13461000000
Quarters > 2 > income Statement > gross Profit
10104000000
Quarters > 2 > income Statement > operating Expenses
6606000000
Quarters > 2 > income Statement > operating Income
3498000000
Quarters > 2 > income Statement > interest Expense
620127875
Quarters > 2 > income Statement > pretax Income
1403000000
Quarters > 2 > income Statement > net Income
1045000000
Quarters > 2 > income Statement > eps
2.3530736320648504
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
444100000
Quarters > 2 > income Statement > income Tax Expense
358000000
Quarters > 2 > income Statement > EBITDA
5857000000
Quarters > 2 > income Statement > operating Margin
14.844048376830044
Quarters > 2 > income Statement > total Other Income Expense Net
-2095000000
Quarters > 2 > balance Sheet > cash
12337000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
11465000000
Quarters > 2 > balance Sheet > inventories
18002000000
Quarters > 2 > balance Sheet > total Current Assets
44086000000
Quarters > 2 > balance Sheet > property Plant Equipment
20510000000
Quarters > 2 > balance Sheet > total Assets
139155000000
Quarters > 2 > balance Sheet > payables
4372000000
Quarters > 2 > balance Sheet > short Term Debt
11314000000
Quarters > 2 > balance Sheet > long Term Debt
24820000000
Quarters > 2 > balance Sheet > total Liabilities
54294000000
Quarters > 2 > balance Sheet > equity
84861000000
Quarters > 2 > cash Flow > net Income
2064025563
Quarters > 2 > cash Flow > depreciation
1016211629
Quarters > 2 > cash Flow > change In Working Capital
184000000
Quarters > 2 > cash Flow > cash From Operations
3720183874
Quarters > 2 > cash Flow > capital Expenditures
1625000000
Quarters > 2 > cash Flow > cash From Investing
-3257012587
Quarters > 2 > cash Flow > cash From Financing
-141500000
Quarters > 2 > cash Flow > net Change In Cash
-7620000000
Quarters > 2 > ratios > PE
2.3530736320648504
Quarters > 2 > ratios > PB
0.03260323352305535
Quarters > 2 > ratios > ROE
1.2314255075947727
Quarters > 2 > ratios > ROA
0.7509611584204664
Quarters > 2 > ratios > FCF
2095183874
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.0889108370040314
Quarters > 2 > health Score
55
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
11782500000
Quarters > 3 > income Statement > cost Of Revenue
6730500000
Quarters > 3 > income Statement > gross Profit
5052000000
Quarters > 3 > income Statement > operating Expenses
3303000000
Quarters > 3 > income Statement > operating Income
1749000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
1403000000
Quarters > 3 > income Statement > net Income
1045000000
Quarters > 3 > income Statement > eps
2.3530736320648504
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
444100000
Quarters > 3 > income Statement > income Tax Expense
358000000
Quarters > 3 > income Statement > EBITDA
2928500000
Quarters > 3 > income Statement > operating Margin
14.844048376830044
Quarters > 3 > income Statement > total Other Income Expense Net
-346000000
Quarters > 3 > balance Sheet > cash
12337000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10299000000
Quarters > 3 > balance Sheet > inventories
18002000000
Quarters > 3 > balance Sheet > total Current Assets
44086000000
Quarters > 3 > balance Sheet > property Plant Equipment
20509000000
Quarters > 3 > balance Sheet > total Assets
139155000000
Quarters > 3 > balance Sheet > payables
4372000000
Quarters > 3 > balance Sheet > short Term Debt
11314000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
54294000000
Quarters > 3 > balance Sheet > equity
84861000000
Quarters > 3 > cash Flow > net Income
1045000000
Quarters > 3 > cash Flow > depreciation
514500000
Quarters > 3 > cash Flow > change In Working Capital
92000000
Quarters > 3 > cash Flow > cash From Operations
1883500000
Quarters > 3 > cash Flow > capital Expenditures
812500000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-141500000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
2.3530736320648504
Quarters > 3 > ratios > PB
0.03260323352305535
Quarters > 3 > ratios > ROE
1.2314255075947727
Quarters > 3 > ratios > ROA
0.7509611584204664
Quarters > 3 > ratios > FCF
1071000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.09089751750477403
Quarters > 3 > health Score
55
Valuation > metrics > PE
-7.81580725061923
Valuation > metrics > PB
0.03259094389407843
Valuation > final Score
70
Valuation > verdict
96.7% Undervalued
Profitability > metrics > ROE
-4.088676333737764
Profitability > metrics > ROA
-8.96852875820371
Profitability > metrics > Net Margin
-0.16217352707564361
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6007562460980292
Risk > metrics > Interest Coverage
3.438063063063063
Risk > final Score
62
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.5316935958657685
Liquidity > metrics > Quick Ratio
1.3536338065022568
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
40
Prev Profitabilities > 1
16
Prev Profitabilities > 2
23
Prev Risks > 0
48
Prev Risks > 1
71
Prev Risks > 2
53
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:24:03.295Z
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Aspen Pharmacare Holdings Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.